...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Annual Financial Reporting
4
Mar 22, 2024 12:55PM
1
Mar 22, 2024 03:10PM
2
Mar 22, 2024 03:46PM
1
Mar 22, 2024 04:17PM
1
Mar 22, 2024 04:57PM

Well I'm counting on one of the many big pharmas etc working with Zenith to act far quicker than waiting on phase 3's to complete years down the road.

Pfizer along with others are hot on various future cancer pipelines etc etc so that's "my hope" in the near term. Hepa has nothing to do with Zenith & Zenith has everything to do with RVX & im betting on that connection for the greatest benifit to all.

glta & have a great weekend!!

2
Mar 23, 2024 10:17AM
1
Mar 23, 2024 06:16PM
1
Mar 23, 2024 07:48PM
3
Mar 23, 2024 08:04PM
1
Mar 23, 2024 08:21PM
Share
New Message
Please login to post a reply